gastroenterology
IBD

Conference ‘agrees to disagree’ on proactive therapeutic drug monitoring in IBD

The thorny issue of proactive therapeutic drug monitoring (TDM) for anti-TNF therapy in IBD patients was the subject of a vociferous debate at DDW 2018, ending in no agreement. While noting that Australian clinicians have recently issued a consensus statement offering cautious support for proactive TDM in some situations, the session at DDW 2018 was ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic